Oligonucleotide Therapeutics Market - Global Outlook and Forecast 2022-2028

January 2022 | 67 pages | ID: O62B7661845BEN
Market Monitor Global

Abstracts

Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.

Although several types of oligonucleotide therapies exist, five of them are compared here, including the ones targeting nucleic acids (such as mRNA) or proteins, as well as others intended for stimulation of the immune system. DDS is generally used with oligonucleotide therapy, as it is difficult for these molecules to penetrate cell membrane when administered on their own.

This report contains market size and forecasts of Oligonucleotide Therapeutics in Global, including the following market information:

Global Oligonucleotide Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Oligonucleotide Therapeutics market was valued at 3784.6 million in 2021 and is projected to reach US$ 10680 million by 2028, at a CAGR of 16.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antisense Oligonucleotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oligonucleotide Therapeutics include Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics and Akcea Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oligonucleotide Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oligonucleotide Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Oligonucleotide Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Antisense Oligonucleotide
• Aptamer
• Other

Global Oligonucleotide Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Oligonucleotide Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Neuromuscular Diseases
• ATTR
• Hepatic VOD
• Other

Global Oligonucleotide Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Oligonucleotide Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oligonucleotide Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Oligonucleotide Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Biogen
• Sarepta Therapeutics
• Jazz Pharmaceuticals
• Bausch & Lomb
• Alnylam Pharmaceuticals
• Dynavax Technologies
• Kastle therapeutics
• Akcea Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oligonucleotide Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oligonucleotide Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OLIGONUCLEOTIDE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Oligonucleotide Therapeutics Market Size: 2021 VS 2028
2.2 Global Oligonucleotide Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oligonucleotide Therapeutics Players in Global Market
3.2 Top Global Oligonucleotide Therapeutics Companies Ranked by Revenue
3.3 Global Oligonucleotide Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Oligonucleotide Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oligonucleotide Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oligonucleotide Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Oligonucleotide Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oligonucleotide Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Oligonucleotide Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Antisense Oligonucleotide
  4.1.3 Aptamer
  4.1.4 Other
4.2 By Type - Global Oligonucleotide Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Oligonucleotide Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Oligonucleotide Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Oligonucleotide Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oligonucleotide Therapeutics Market Size, 2021 & 2028
  5.1.2 Neuromuscular Diseases
  5.1.3 ATTR
  5.1.4 Hepatic VOD
  5.1.5 Other
5.2 By Application - Global Oligonucleotide Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Oligonucleotide Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Oligonucleotide Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Oligonucleotide Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Oligonucleotide Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Oligonucleotide Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Oligonucleotide Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Oligonucleotide Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Oligonucleotide Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Oligonucleotide Therapeutics Revenue, 2017-2028
  6.3.2 US Oligonucleotide Therapeutics Market Size, 2017-2028
  6.3.3 Canada Oligonucleotide Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Oligonucleotide Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Oligonucleotide Therapeutics Revenue, 2017-2028
  6.4.2 Germany Oligonucleotide Therapeutics Market Size, 2017-2028
  6.4.3 France Oligonucleotide Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Oligonucleotide Therapeutics Market Size, 2017-2028
  6.4.5 Italy Oligonucleotide Therapeutics Market Size, 2017-2028
  6.4.6 Russia Oligonucleotide Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Oligonucleotide Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Oligonucleotide Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Oligonucleotide Therapeutics Revenue, 2017-2028
  6.5.2 China Oligonucleotide Therapeutics Market Size, 2017-2028
  6.5.3 Japan Oligonucleotide Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Oligonucleotide Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Oligonucleotide Therapeutics Market Size, 2017-2028
  6.5.6 India Oligonucleotide Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Oligonucleotide Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Oligonucleotide Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Oligonucleotide Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oligonucleotide Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Oligonucleotide Therapeutics Market Size, 2017-2028
  6.7.3 Israel Oligonucleotide Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Oligonucleotide Therapeutics Market Size, 2017-2028
  6.7.5 UAE Oligonucleotide Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Biogen
  7.1.1 Biogen Corporate Summary
  7.1.2 Biogen Business Overview
  7.1.3 Biogen Oligonucleotide Therapeutics Major Product Offerings
  7.1.4 Biogen Oligonucleotide Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Biogen Key News
7.2 Sarepta Therapeutics
  7.2.1 Sarepta Therapeutics Corporate Summary
  7.2.2 Sarepta Therapeutics Business Overview
  7.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Major Product Offerings
  7.2.4 Sarepta Therapeutics Oligonucleotide Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Sarepta Therapeutics Key News
7.3 Jazz Pharmaceuticals
  7.3.1 Jazz Pharmaceuticals Corporate Summary
  7.3.2 Jazz Pharmaceuticals Business Overview
  7.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Major Product Offerings
  7.3.4 Jazz Pharmaceuticals Oligonucleotide Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Jazz Pharmaceuticals Key News
7.4 Bausch & Lomb
  7.4.1 Bausch & Lomb Corporate Summary
  7.4.2 Bausch & Lomb Business Overview
  7.4.3 Bausch & Lomb Oligonucleotide Therapeutics Major Product Offerings
  7.4.4 Bausch & Lomb Oligonucleotide Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Bausch & Lomb Key News
7.5 Alnylam Pharmaceuticals
  7.5.1 Alnylam Pharmaceuticals Corporate Summary
  7.5.2 Alnylam Pharmaceuticals Business Overview
  7.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Major Product Offerings
  7.5.4 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Alnylam Pharmaceuticals Key News
7.6 Dynavax Technologies
  7.6.1 Dynavax Technologies Corporate Summary
  7.6.2 Dynavax Technologies Business Overview
  7.6.3 Dynavax Technologies Oligonucleotide Therapeutics Major Product Offerings
  7.6.4 Dynavax Technologies Oligonucleotide Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Dynavax Technologies Key News
7.7 Kastle therapeutics
  7.7.1 Kastle therapeutics Corporate Summary
  7.7.2 Kastle therapeutics Business Overview
  7.7.3 Kastle therapeutics Oligonucleotide Therapeutics Major Product Offerings
  7.7.4 Kastle therapeutics Oligonucleotide Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Kastle therapeutics Key News
7.8 Akcea Therapeutics
  7.8.1 Akcea Therapeutics Corporate Summary
  7.8.2 Akcea Therapeutics Business Overview
  7.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Major Product Offerings
  7.8.4 Akcea Therapeutics Oligonucleotide Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Akcea Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Oligonucleotide Therapeutics Market Opportunities & Trends in Global Market
Table 2. Oligonucleotide Therapeutics Market Drivers in Global Market
Table 3. Oligonucleotide Therapeutics Market Restraints in Global Market
Table 4. Key Players of Oligonucleotide Therapeutics in Global Market
Table 5. Top Oligonucleotide Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Oligonucleotide Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Oligonucleotide Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Oligonucleotide Therapeutics Product Type
Table 9. List of Global Tier 1 Oligonucleotide Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oligonucleotide Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oligonucleotide Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Oligonucleotide Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Oligonucleotide Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Oligonucleotide Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Oligonucleotide Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Oligonucleotide Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Oligonucleotide Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Oligonucleotide Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Oligonucleotide Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Oligonucleotide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Oligonucleotide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Oligonucleotide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Oligonucleotide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Oligonucleotide Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Biogen Corporate Summary
Table 31. Biogen Oligonucleotide Therapeutics Product Offerings
Table 32. Biogen Oligonucleotide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Sarepta Therapeutics Corporate Summary
Table 34. Sarepta Therapeutics Oligonucleotide Therapeutics Product Offerings
Table 35. Sarepta Therapeutics Oligonucleotide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Jazz Pharmaceuticals Corporate Summary
Table 37. Jazz Pharmaceuticals Oligonucleotide Therapeutics Product Offerings
Table 38. Jazz Pharmaceuticals Oligonucleotide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Bausch & Lomb Corporate Summary
Table 40. Bausch & Lomb Oligonucleotide Therapeutics Product Offerings
Table 41. Bausch & Lomb Oligonucleotide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Alnylam Pharmaceuticals Corporate Summary
Table 43. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Product Offerings
Table 44. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Dynavax Technologies Corporate Summary
Table 46. Dynavax Technologies Oligonucleotide Therapeutics Product Offerings
Table 47. Dynavax Technologies Oligonucleotide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Kastle therapeutics Corporate Summary
Table 49. Kastle therapeutics Oligonucleotide Therapeutics Product Offerings
Table 50. Kastle therapeutics Oligonucleotide Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Akcea Therapeutics Corporate Summary
Table 52. Akcea Therapeutics Oligonucleotide Therapeutics Product Offerings
Table 53. Akcea Therapeutics Oligonucleotide Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Oligonucleotide Therapeutics Segment by Type in 2021
Figure 2. Oligonucleotide Therapeutics Segment by Application in 2021
Figure 3. Global Oligonucleotide Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oligonucleotide Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oligonucleotide Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oligonucleotide Therapeutics Revenue in 2021
Figure 8. By Type - Global Oligonucleotide Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Oligonucleotide Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Oligonucleotide Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Oligonucleotide Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Oligonucleotide Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Oligonucleotide Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Oligonucleotide Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Oligonucleotide Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Oligonucleotide Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Biogen Oligonucleotide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sarepta Therapeutics Oligonucleotide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Jazz Pharmaceuticals Oligonucleotide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bausch & Lomb Oligonucleotide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Dynavax Technologies Oligonucleotide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Kastle therapeutics Oligonucleotide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Akcea Therapeutics Oligonucleotide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)